Logo image
Back
POGLUT1 biallelic mutations cause myopathy with reduced satellite cells, α-dystroglycan hypoglycosylation and a distinctive radiological pattern
Journal article   Open access   Peer reviewed

POGLUT1 biallelic mutations cause myopathy with reduced satellite cells, α-dystroglycan hypoglycosylation and a distinctive radiological pattern

E Servián-Morilla, M Cabrera-Serrano, K Johnson, A Pandey, A Ito, E Rivas, T Chamova, N Muelas, T Mongini, S Nafissi, …
Acta neuropathologica, Vol.139(3), pp.565-582
03/2020
DOI: 10.1007/s00401-019-02117-6
PMCID: PMC7196238
PMID: 31897643
url
https://doi.org/10.1007/s00401-019-02117-6View
Published (Version of record) Open Access

Abstract

Protein O-glucosyltransferase 1 (POGLUT1) activity is critical for the Notch signaling pathway, being one of the main enzymes responsible for the glycosylation of the extracellular domain of Notch receptors. A biallelic mutation in the POGLUT1 gene has been reported in one family as the cause of an adult-onset limb-girdle muscular dystrophy (LGMD R21; OMIM# 617232). As the result of a collaborative international effort, we have identified the first cohort of 15 patients with LGMD R21, from nine unrelated families coming from different countries, providing a reliable phenotype-genotype and mechanistic insight. Patients carrying novel mutations in POGLUT1 all displayed a clinical picture of limb-girdle muscle weakness. However, the age at onset was broadened from adult to congenital and infantile onset. Moreover, we now report that the unique muscle imaging pattern of "inside-to-outside" fatty degeneration observed in the original cases is indeed a defining feature of POGLUT1 muscular dystrophy. Experiments on muscle biopsies from patients revealed a remarkable and consistent decrease in the level of the NOTCH1 intracellular domain, reduction of the pool of satellite cells (SC), and evidence of α-dystroglycan hypoglycosylation. In vitro biochemical and cell-based assays suggested a pathogenic role of the novel POGLUT1 mutations, leading to reduced enzymatic activity and/or protein stability. The association between the POGLUT1 variants and the muscular phenotype was established by in vivo experiments analyzing the indirect flight muscle development in transgenic Drosophila, showing that the human POGLUT1 mutations reduced its myogenic activity. In line with the well-known role of the Notch pathway in the homeostasis of SC and muscle regeneration, SC-derived myoblasts from patients' muscle samples showed decreased proliferation and facilitated differentiation. Together, these observations suggest that alterations in SC biology caused by reduced Notch1 signaling result in muscular dystrophy in LGMD R21 patients, likely with additional contribution from α-dystroglycan hypoglycosylation. This study settles the muscular clinical phenotype linked to POGLUT1 mutations and establishes the pathogenic mechanism underlying this muscle disorder. The description of a specific imaging pattern of fatty degeneration and muscle pathology with a decrease of α-dystroglycan glycosylation provides excellent tools which will help diagnose and follow up LGMD R21 patients.
 Animals Animals, Genetically Modified Drosophila melanogaster Dystroglycans - metabolism Female Genetic Association Studies Glucosyltransferases - genetics Glycosylation Humans Male Muscle, Skeletal - metabolism Muscle, Skeletal - pathology Muscular Dystrophies, Limb-Girdle - genetics Muscular Dystrophies, Limb-Girdle - metabolism Muscular Dystrophies, Limb-Girdle - pathology Mutation Pedigree Satellite Cells, Skeletal Muscle - pathology

Details

Metrics

14 Record Views
31 Times Cited - Web of Science
Logo image